Promotes prostate cancer growth by (1) repressing CTBP1 via the recruitment of PSF and HDAC and (2) promoting cell cycle progression by inhibiting tumor suppressor genes via AR. This evidence concerns the gene HDAC9 and prostate carcinoma.